Proceedings: The relation between the plasma concentration of edrophonium, inhibition of erythrocyte acetylcholinesterase, and the facilitation of neuromuscular function in the rat

. 1975 Jun;54(2):263P–264P.

Proceedings: The relation between the plasma concentration of edrophonium, inhibition of erythrocyte acetylcholinesterase, and the facilitation of neuromuscular function in the rat.

PMCID: PMC1666605 PMID: 1148545

These references are in PubMed. This may not be the complete list of references from this article.

Back D. J., Calvey T. N. The pharmacokinetics of (14C)-edrophonium in normal wistar rats and homozygous Gunn rats with ligated renal pedicles. Br J Pharmacol. 1974 May;51(1):61–65. doi: 10.1111/j.1476-5381.1974.tb09632.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Back D. J., Calvey T. N. The removal of 14 C-edrophonium from the circulation. Br J Pharmacol. 1972 Oct;46(2):355–357. doi: 10.1111/j.1476-5381.1972.tb06882.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Potter L. T. A radiometric microassay of acetylcholinesterase. J Pharmacol Exp Ther. 1967 Jun;156(3):500–506. [PubMed] [Google Scholar]
RANDALL L. O. Anticurare action of phenolic quaternary ammonium salts. J Pharmacol Exp Ther. 1950 Sep;100(1):83–93. [PubMed] [Google Scholar]
Smith M. H. Determination of blood acetylcholinesterase inhibition caused by reversible inhibitors in vivo. Biochem Med. 1974 Jul;10(3):236–244. doi: 10.1016/0006-2944(74)90027-1. [DOI] [PubMed] [Google Scholar]